1. Home
  2. TG vs DCTH Comparison

TG vs DCTH Comparison

Compare TG & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$8.31

Market Cap

353.3M

Sector

Industrials

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$11.32

Market Cap

363.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
DCTH
Founded
1988
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.3M
363.5M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
TG
DCTH
Price
$8.31
$11.32
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$22.00
AVG Volume (30 Days)
158.5K
337.9K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
107.53
EPS
0.17
N/A
Revenue
$800,821,000.00
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
N/A
$33.15
P/E Ratio
$55.47
N/A
Revenue Growth
8.29
N/A
52 Week Low
$6.25
$8.12
52 Week High
$10.53
$18.23

Technical Indicators

Market Signals
Indicator
TG
DCTH
Relative Strength Index (RSI) 39.25 58.13
Support Level $7.30 $10.17
Resistance Level $9.03 $11.99
Average True Range (ATR) 0.60 0.55
MACD -0.10 0.01
Stochastic Oscillator 3.60 56.76

Price Performance

Historical Comparison
TG
DCTH

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: